1. Medtech Insight

New Product Briefs

Product announcements from St. Jude, Medtronic, BD, Masimo and Fujifilm Medical.

FDA approved St. Jude Medical Inc.'s MultiPoint Pacing (MPP) technology on several cardiac resynchronization therapy devices, the firm announced Feb. 17. It is a first-to-market capability, St. Jude said, allowing physicians to activate more ventricular tissue faster upon implant of a CRT device to improve the chances of treatment response. The MPP feature on St. Jude's Quadra Assura M cardiac defibrillator (CRT-D), the Quadra Allure MP CRT-pacemaker (CRT-P), and two new quadripolar Quartet LV leads will be available to physicians in the first half of the year, the company said, which is a bit sooner than prior estimates.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

Ireland’s Medtech Keeps Calm While Trump Covets Its Healthcare Industry

 
• By Amanda Maxwell

The Republic of Ireland’s record in life sciences is impressive. Decades of investment, education and training have been major winners for the country’s successful economy. But its success is drawing unwanted attention from the US. Trump wants “to have that.”

Keep An Eye On Landmark Global Pandemic Treaty, Experts Advise

 
• By Neena Brizmohun

Mechanisms in the draft treaty that the more than 190 member states of the World Health Organization have finally agreed to are expected to “materially affect companies,” particularly those that develop, manufacture or distribute pandemic-related health care products.

New Semiconductor Tariffs Could Raise Device Costs

 
• By Elizabeth Orr

Proposed tariffs on semiconductors from President Donald Trump could significantly raise costs for the US medical device industry. Current domestic production cannot meet demand, spurring concerns about potential price increases for consumers and healthcare systems.